Mediclever

What Mediclever does

Mediclever Ltd. is a UK-headquartered, privately-held medical device reimbursement consulting firm founded in 2007. The company helps medical device manufacturers and life sciences companies navigate the 'reimbursement gap' between regulatory clearance and predictable clinical payment by designing and executing market access frameworks across coding, coverage, and payment layers. Service lines include Reimbursement Strategy Consulting, Distributor Allocation Services, Reimbursement Landscape Analysis, Evidence Requirements Planning, and Market Access Implementation, supported by a proprietary Pseudo Dossier methodology that enables early payer validation for early-stage devices. Mediclever operates with 11–50 employees and three offices in London, Wilmington (Delaware, USA), and Herzliya (Israel), serving clients across 15+ markets spanning North America, Europe, the Middle East, and Asia-Pacific.

The firm commercializes expertise through flat-fee, multi-year consulting engagements with transparent timelines and disclosed scope — atypical for the professional services norm of hourly billing. Its competitive position rests on a talent network that includes former Medicare Medical Directors, Payer Policy Experts, and health economists, alongside deep jurisdictional expertise in country-specific mechanisms such as Germany's NUB and DiGA pathways, France's LPPR and PECAN, the US CMS RAPID pathway, and Switzerland's TARDOC coding regime. Customer segmentation spans MedTech startups through Fortune 500 medical device manufacturers, with the firm having served over 200 clients cumulatively across its operational history. Marketing relies on thought-leadership content, verified client testimonials, free consultation requests, and presence at major industry events including The MedTech Conference and the JPM Healthcare Conference.

The underlying technology is codified consulting methodology rather than a software product; there is no proprietary platform, no app, no API, and no disclosed use of AI or machine learning. Mediclever is founder-led by Amir Inbar and has operated continuously without disclosed venture capital or private equity investment, M&A activity, or ownership change since founding. The business model is professional services revenue — fees tied to engagement scope rather than per-transaction software subscriptions — which constrains scalability but supports high-margin human-delivered advisory work.

Name

Mediclever

Legal name

Mediclever Ltd.

Website

https://mediclever.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Mediclever is a UK-based, privately-held medical device reimbursement consultancy serving startups through Fortune 500 manufacturers across 15+ markets. It offers flat-fee, multi-year engagements covering coding, coverage, payment, and market access strategy, leveraging former Medicare Medical Directors and payer policy experts.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Reimbursement Consulting Services: Mediclever generates revenue through specialized consulting engagements focused on medical device reimbursement strategy. They provide services including reimbursement landscape analysis, evidence strategy development, coding applications, coverage expansion, and market access execution. Their model involves direct client engagements with commercial medical device companies, pharmaceutical firms, and life sciences organizations seeking to navigate global payer systems.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Mediclever is a specialized medical device reimbursement consultancy that designs and executes market access frameworks for MedTech and life sciences companies. Its services span coding strategy (HCPCS, CPT, country-specific codes), coverage strategy (clinical evidence dossiers and payer policy determinations), and payment negotiation (rates and hospital add-on funding such as NUB in Germany and LPPR in France). The firm serves clients across more than 15 markets through offices in London, Wilmington (US), and Herzliya (Israel).

Product overview

Mediclever is a global medical device reimbursement consulting firm offering strategic consulting services rather than a traditional software product. The core offerings include Reimbursement Strategy Consulting and Distributor Allocation Services, supported by three methodological components: Reimbursement Landscape Analysis, Evidence Requirements Planning, and Market Access Implementation. Regional specializations cover major markets including the USA (CMS, CPT, RAPID pathway), Germany (G-BA, NUB, DiGA), France (HAS, LPPR, PECAN), UK (NICE, OPCS, HRG), Italy, Canada, Switzerland, Belgium, Spain, and Netherlands. Key service components include Coding Strategy (securing HCPCS/CPT/country-specific codes), Coverage Strategy (clinical evidence dossiers), and Payment Rate Negotiation (NUB/LPPR hospital add-on funding). The firm also offers specialized workshops and Pseudo Dossier development using lean startup methodology for early payer validation. Founded in 2007 with offices in London, Wilmington DE, and Herzliya Israel, Mediclever serves over 200 clients globally with a team of former Medicare Medical Directors and Payer Policy Experts.

Differentiator

Problem solved

Functional benefit

Products and services

• Reimbursement Strategy Consulting Strategic consulting service designing and executing market access frameworks that align regulatory clearance with predictable clinical payment, including analyzing payer policies, securing billing codes, building health economic evidence models, and managing applications to insurance medical directors globally. Targeted at medical device manufacturers and life sciences companies.
• Distributor Allocation Services Medical device distributor allocation and market optimization consulting helping clients identify and engage appropriate distribution channels across global markets.
• US Market Access Strategy Payer-validated market access solutions, CPT/HCPCS coding infrastructure, and execution frameworks for US medical device reimbursement including CMS regulatory alignment for the RAPID pathway.
• Germany Reimbursement Strategy Guidance on OPS, EBM, GOÄ coding systems, DiGA pathway, NUB applications, and inclusion in the Medical Aids Directory for German market access.
• France Reimbursement Strategy Expert guidance with CCAM v.81, PECAN fast-track for digital health, GHM/GHS codes, and listing in the LPPR for French market access.
• UK Reimbursement Strategy Guidance on OPCS-4.11 coding, HRGs, NICE HealthTech Programme, and ICB reimbursement pathways for England and UK market access.
• Italy Reimbursement Strategy Guidance on LEA eligibility, DRG tariffs, and regional decision makers including ASR, ASL, and AGENAS for Italian market access.
• Canada Reimbursement Strategy Expert guidance on CCI codes, provincial fee schedules, CMG+ system, and hospital Quality Based Procedures (QBP) for Canadian market access.
• Reimbursement Strategy Workshop Tailored medical device reimbursement strategy workshop for MedTech executives, coordinated via email.
• Pseudo Dossier Development Lean startup-inspired early-stage version of reimbursement applications using estimated results to create value stories for early validation with payers before generating actual clinical evidence.

Quantifiable outcome

• 200+ clients successfully guided through code applications, coverage expansions, and market access launches
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lumanity: Newly combined entity (including Bridgeable and other consultancies) offering integrated medical, payer, and patient evidence and market access services. Directly comparable to Mediclever's payer-engagement and reimbursement-strategy service lines.
• Health Advances: Healthcare strategy consultancy focused on MedTech and life sciences clients, with explicit practice in reimbursement strategy, clinical evidence, and market access. A near-direct peer in scope and client base.
• Evidera (Pharmalex): Evidence synthesis, health economics, and market access consulting firm serving biopharma and MedTech clients. Directly comparable to Mediclever as both monetize payer-insider expertise on global market access projects for medical product manufacturers.
• ZS Associates: Global consulting firm with a large dedicated healthcare practice covering market access, pricing, and reimbursement strategy. Comparable to Mediclever in serving MedTech and pharma clients on payer-engagement and evidence-strategy engagements.
• CBPartners (Lumanity): Specialized pricing, market access, and value communications consultancy. Closely mirrors Mediclever's payer-engagement and reimbursement-strategy model for MedTech and pharmaceutical manufacturers.

Broad incumbents

• McKinsey & Company (Healthcare Practice): Top-tier strategy consultancy with deep healthcare and MedTech practices that frequently include market access and reimbursement strategy as part of broader commercial transformations.
• IQVIA: Global CRO and healthcare analytics leader with a substantial market access and real-world evidence practice. Comparable in function (payer strategy, evidence generation) but at far greater scale and with cross-sell across clinical and commercial offerings.
• ICON plc: Major CRO with market access and commercialization services that compete with Mediclever for MedTech reimbursement engagements, typically bundled with broader clinical development offerings.
• Charles River Associates (CRA): Large global consulting firm with a Life Sciences practice offering health economics and market access services. Overlaps with Mediclever but serves a much broader portfolio of strategy and economics engagements.

Emerging players

• LSC Life Science Consultants: Smoulder specialized life sciences and MedTech strategy consultancy providing regulatory, clinical, and market access support. Comparable niche positioning and client type, though smaller and less globally distributed than Mediclever.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/mediclever
• Facebookfacebook.com/mediclever
• LinkedInlinkedin.com/company/mediclever

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mediclever